Associate Professor of Psychiatry, Massachusetts General Hospital
Psychiatry
Dr. Naomi M. Simon, MD
|
|
Give Review
Naomi Simon works in the field of Psychiatry. She graduated from Harvard Medical School. Harvard Medical School is a one of the best medicals schools. Harvard Medical School has a rank of 1 in research and a 12 in primary care Naomi Simon is a published MD. She published 101 publications, including: 'Dizziness and panic disorder: a review of the association between vestibular dysfunction and anxiety.' She accepts Medicare payments and is registered with Medicare.gov.
Publications
- Bereavement: course, consequences, and care.
- De novo fear conditioning across diagnostic groups in the affective Disorders: evidence for learning impairments.
- Neuroscience of fear extinction: Implications for assessment and treatment of fear-based and anxiety related Disorders.
- Grief-related panic symptoms in Complicated Grief.
- The impact of losing a child on the clinical presentation of complicated grief.
- Gender moderates the effect of oxytocin on social judgments.
- Gender differences in oxytocin-associated disruption of decision bias during emotion perception.
- The Human Ortholog of Acid-Sensing Ion Channel Gene ASIC1a Is Associated with Panic Disorder and Amygdala Structure and Function.
- D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety Disorder: Prognostic and prescriptive variables.
- Influence of RGS2 on Sertraline Treatment for Social Anxiety Disorder.
- Dreams of the Dead Among Cambodian Refugees: Frequency, Phenomenology, and Relationship to Complicated Grief and Posttraumatic Stress Disorder.
- Two weeks of pretreatment with escitalopram facilitates extinction learning in healthy individuals.
- Smiles may go unseen in generalized social anxiety Disorder: Evidence from binocular rivalry for reduced visual consciousness of positive facial expressions.
- CORTICO-LIMBIC RESPONSES TO MASKED AFFECTIVE FACES ACROSS PTSD, PANIC Disorder, AND SPECIFIC PHOBIA.
- Treating complicated grief.
- Normal Grief and Complicated Bereavement Among Traumatized Cambodian Refugees: Cultural Context and the Central Role of Dreams of the Dead.
- Loving-Kindness Meditation practice associated with longer telomeres in women.
- Panic-agoraphobic spectrum symptoms in complicated grief.
- COMPLICATED GRIEF SYMPTOMS IN ANXIETY DisorderS: PREVALENCE AND ASSOCIATED IMPAIRMENT.
- Randomized controlled trial of mindfulness meditation for generalized anxiety Disorder: effects on anxiety and stress reactivity.
- PERILOSS DISSOCIATION, SYMPTOM SEVERITY, AND TREATMENT RESPONSE IN COMPLICATED GRIEF.
- PLASMA OXYTOCIN IMMUNOREACTIVE PRODUCTS AND RESPONSE TO TRUST IN PATIENTS WITH SOCIAL ANXIETY Disorder.
- Avoidant personality Disorder in individuals with generalized social anxiety Disorder: What does it add?
- Body Piercings and Posttraumatic Stress Disorder Symptoms in Young Adults.
- Peritraumatic reactions and posttraumatic stress Disorder symptoms after psychiatric admission.
- Understanding the relationship of perceived social support to post-trauma cognitions and posttraumatic stress Disorder.
- Effects of a psychiatric label on medical residents' attitudes.
- Complicated grief among individuals with Major depression: Prevalence, comorbidity, and associated features.
- Eszopiclone for the treatment of posttraumatic stress Disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial.
- Informing the symptom profile of complicated grief.
- Bereavement, complicated grief, and DSM, part 2: complicated grief.
- Duloxetine for the treatment of generalized social anxiety Disorder: a preliminary randomized trial of increased dose to optimize response.
- Levetiracetam in generalized social anxiety Disorder: a double-blind, randomized controlled trial.
- Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic Disorder.
- Next-step strategies for panic Disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial.
- Childhood maltreatment linked to greater symptom severity and poorer quality of life and function in social anxiety Disorder.
- A PET study of tiagabine treatment implicates ventral medial prefrontal cortex in generalized social anxiety Disorder.
- Open-label support for duloxetine for the treatment of panic Disorder.
- Generalized anxiety Disorder and psychiatric comorbidities such as depression, bipolar Disorder, and substance abuse.
- Aripiprazole as augmentation treatment of refractory generalized anxiety Disorder and panic Disorder.
- Anxiety is associated with impulsivity in bipolar Disorder.
- Paroxetine CR augmentation for posttraumatic stress Disorder refractory to prolonged exposure therapy.
- Oxytocin levels in social anxiety Disorder.
- Novel treatment approaches for refractory anxiety Disorders.
- Examination of the decline in symptoms of anxiety and depression in generalized anxiety Disorder: impact of anxiety sensitivity on response to pharmacotherapy.
- Complicated grief: a case series using escitalopram.
- The prevalence and correlates of psychiatric comorbidity in individuals with complicated grief.
- A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic Disorder.
- Cross-cultural differences in somatic presentation in patients with generalized anxiety Disorder.
- The relationship of anxiety Disorders, anxiety sensitivity and pulmonary dysfunction with dyspnea-related distress and avoidance.
- Telomere shortening and mood Disorders: preliminary support for a chronic stress model of accelerated aging.
- Persistent posttraumatic stress Disorder following September 11 in patients with bipolar Disorder.
- An open-label trial of risperidone augmentation for refractory anxiety Disorders.
- Augmentation of exposure therapy with D-cycloserine for social anxiety Disorder.
- Olanzapine augmentation of fluoxetine for refractory generalized anxiety Disorder: a placebo controlled study.
- Preliminary support for gender differences in response to fluoxetine for generalized anxiety Disorder.
- Rates of isolated sleep paralysis in outpatients with anxiety Disorders.
- Baseline predictors of serious adverse events at one year among patients with bipolar Disorder in STEP-BD.
- Untangling depression and Anxiety: clinical challenges.
- Complicated grief and its correlates in patients with bipolar Disorder.
- Fluoxetine for vestibular dysfunction and Anxiety: a prospective pilot study.
- The implications of medical and psychiatric comorbidity with panic Disorder.
- Anxiety Disorder comorbidity in bipolar Disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (S...
- An open-label study of levetiracetam for the treatment of social anxiety Disorder.
- Combined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic Disorder.
- Bupropion sustained release for panic Disorder.
- Citalopram for social anxiety Disorder: an open-label pilot study in refractory and nonrefractory patients.
- Quality of life in social anxiety Disorder compared with panic Disorder and the general population.
- Efficacy of CBT for benzodiazepine discontinuation in patients with panic Disorder: Further evaluation.
- A comparison of emotional approach coping (EAC) between individuals with anxiety Disorders and nonanxious controls.
- Cigarette smoking is associated with suicidality in bipolar Disorder.
- The association of comorbid anxiety Disorders with suicide attempts and suicidal ideation in outpatients with bipolar Disorder.
- Brain GABA levels in patients with bipolar Disorder.
- Complicated grief and impaired sleep in patients with bipolar Disorder.
- High-field MRS study of GABA, glutamate and glutamine in social anxiety Disorder: response to treatment with levetiracetam.
- Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety Disorder: preliminary findings.
- Impact of concurrent naturalistic pharmacotherapy on psychotherapy of complicated grief.
- A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic Disorder.
- Pharmacotherapy for bipolar Disorder and comorbid conditions: baseline data from STEP-BD.
- Changes in anxiety sensitivity with pharmacotherapy for panic Disorder.
- Does recovery from substance use Disorder matter in patients with bipolar Disorder?
- Understanding the link between anxiety symptoms and suicidal ideation and behaviors in outpatients with bipolar Disorder.
- Panic Disorder and bipolar Disorder: anxiety sensitivity as a potential mediator of panic during manic states.
- Comparing anxiety Disorders and anxiety-related traits in bipolar Disorder and unipolar depression.
- Valproic acid for the treatment of social anxiety Disorder.
- Longitudinal outcome with pharmacotherapy in a naturalistic study of panic Disorder.
- Hypothyroidism and hyperthyroidism in anxiety Disorders revisited: new data and literature review.
- Citalopram for social phobia: a clinical case series.
- Predictors of outcome following venlafaxine extended-release treatment of DSM-IV generalized anxiety Disorder: a pooled analysis of short- and long-term studies.
- Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity Disorder comorbidity in adults with bipolar Disorder: data from the first 1000 STEP-BD...
- Broad spectrum of cytokine abnormalities in panic Disorder and posttraumatic stress Disorder.
- The role of anxiety sensitivity in sleep disturbance in panic Disorder.
- Complicated grief and related bereavement issues for DSM-5.
- Bereavement, complicated grief, and DSM, part 1: depression.
- Anxiety in patients with pulmonary disease: comorbidity and treatment.
- Dizziness and panic Disorder: a review of the association between vestibular dysfunction and anxiety.
- Ropinirole for antidepressant-induced sexual dysfunction.
- Clinician response to treatment refractory panic Disorder: a survey of psychiatrists.
- Prospective 12-month course of bipolar Disorder in out-patients with and without comorbid anxiety Disorders.
- A detailed examination of cytokine abnormalities in Major Depressive Disorder.
Schools
Harvard Medical School
Columbia Presbyterian Med
Massachusetts General Hospital
Procedures Preformed
- Psychotherapy and Psychophysiological Therapy (incl. Biofeedback)
Conditions Treated
- Adjustment Disorder
- Anxiety
- Major Depressive Disorder
- Post-Traumatic Stress Disorder (PTSD)
Doctors Specialties
- Psychiatry
Accepted Insurances
Education
-
New York Presbyterian Hospital - Columbia Campus -
Harvard Medical School
Hospital
-
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1831218031 | |
| NPPES Provider LastName | SIMON | |
| NPPES Provider FirstName | NAOMI | |
| NPPES Provider ZIPCode | 281179247 | |
| NPPES Provider State | NC | |
| Specialty Description | Dermatology | |
| Total Claim Count | 575.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1831218031 |
| Last Name Of The Provider | SIMON |
| First Name Of The Provider | NAOMI |
| View All |
Similar Doctors
|
|
Dr. Alexandra A. Sibley, MD |
|
|
Dr. Hermioni N. Lokko, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hannah E. Brown, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brittany B. Albright, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nora S. Brooke, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Feyza Marouf, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jay W. Baer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Miriam R. Freidin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Emily M. Sullivan, DO |
|
|
Dr. Jing Bu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Noor M. Albar, MD |
|
|
Dr. Emily L. Porch, MD |